drugset / Trial / NCT02195466

Effects of Single-dose and Steady-state TPV/RTV on the Steady-state Pharmacokinetics of Fluconazole in Healthy Adult Volunteers

NCT02195466

Phase 1 Completed 20 enrolled Boehringer Ingelheim
NaSingle-groupOpen-labelTreatment

Summary

Study to determine the effects of single-dose and steady-state TPV/RTV 500/200 mg on the steady-state pharmacokinetics of fluconazole

Timeline

Start
2003-06
Primary completion
2003-07
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Fluconazole Small molecule 100 mg
Subject Ritonavir Other / unclassified 200 mg
Subject Tipranavir Small molecule 500 mg

Indications

No indication recorded.